Metabolic Aspects of Chronic Liver Disease
Seiten
2008
Nova Science Publishers Inc (Verlag)
978-1-60021-201-7 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-60021-201-7 (ISBN)
Discusses various aspects of the metabolic basis of important chronic liver diseases. This book also discusses entities, such as non-alcoholic fatty liver disease, diabetes in chronic hepatitis C, hemochromatosis, Wilson's disease, Gaucher disease, porphyria, as well as liver cirrhosis and its metabolic consequences.
This book discusses in detail new aspects of the metabolic basis of important chronic liver diseases. Entities such as non-alcoholic fatty liver disease (fatty liver and Non-Alcoholic SteatoHepatitis -- NASH), diabeties in chronic hepetitis C, hemochromatosis, Wilson's disease, Gaucher disease, porphyria, as well as liver cirrhosis and its metabolic consequences will be discussed in detail. These clinical conditions are highly prevalent and affect millions of patients in the USA and world-wide. For example, non-alcoholic fatty liver disease is the most common cause of elevated liver enzymes in the general population. This field has been practically transformed over the last few years, with many new insights gained, regarding both pathogenesis and effective novel treatments.
This book discusses in detail new aspects of the metabolic basis of important chronic liver diseases. Entities such as non-alcoholic fatty liver disease (fatty liver and Non-Alcoholic SteatoHepatitis -- NASH), diabeties in chronic hepetitis C, hemochromatosis, Wilson's disease, Gaucher disease, porphyria, as well as liver cirrhosis and its metabolic consequences will be discussed in detail. These clinical conditions are highly prevalent and affect millions of patients in the USA and world-wide. For example, non-alcoholic fatty liver disease is the most common cause of elevated liver enzymes in the general population. This field has been practically transformed over the last few years, with many new insights gained, regarding both pathogenesis and effective novel treatments.
Pathophysiology of NASH; Nonalcoholic Fatty Liver Disease and NASH: Clinical and Histological Aspects; The Treatment of Non-Alcoholic Fatty Liver Disease -- an Entity in Evolution; The Hepatitis C Virus and Diabetes Mellitus Association: Characterisation and Studies of Risk Factors, Mechanisms, Implications & Treatment; Hereditary Hemochromatosis; Iron in Chronic Liver Disease; Wilson Disease; Gaucher Disease; The Clinical Features and Pathobiology of Alpha1-Antitrypsin Deficiency; Glycogen Storage Diseases; Liver Transplantation for Metabolic Disease; Index.
| Erscheint lt. Verlag | 17.3.2008 |
|---|---|
| Zusatzinfo | Illustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 260 x 180 mm |
| Gewicht | 986 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hepatologie |
| ISBN-10 | 1-60021-201-8 / 1600212018 |
| ISBN-13 | 978-1-60021-201-7 / 9781600212017 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Diagnostik, Differenzialdiagnostik, Therapieansätze
Buch (2016)
Thieme (Verlag)
CHF 148,80
Buch | Softcover (2020)
Wiley-Blackwell (Verlag)
CHF 119,95
Buch | Hardcover (2023)
Elsevier - Health Sciences Division (Verlag)
CHF 369,95
